An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion

Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

OBJECTIVES. This study investigated whether an antibody against neutrophil adhesion protein CD18 could limit myocardial infarct size and preserve left ventricular function after prolonged reperfusion in a canine model. BACKGROUND. Myocardial reperfusion injury is mediated in part by accumulation of activated neutrophils. Although antibodies against CD18 have been shown to reduce neutrophil influx and infarct size after ischemia and 3 to 4 h of reperfusion, it is unknown whether protection is sustained beyond this time or whether there is meaningful preservation of ventricular function. METHODS. Dogs undergoing 90-min circumflex coronary artery occlusion and 48-h reperfusion were randomized to receive 1 mg/kg bodyweight of R15.7 (an anti-CD18 antibody, n = 12) or saline (control, n =12) 10 min before reperfusion. Contrast left ventriculography was used to measure left ventricular ejection fraction and regional chord shortening at baseline, during occlusion and at 48 h. Microspheres injected during occlusion were used to measure collateral flow and risk region size. Postmortem infarct size was measured with triphenyltetrazolium chloride. RESULTS. In the dose administered, R15.7 bound to neutrophils in vivo, with >85% saturation of CD18 for >24 h, with sustained antibody excess in the plasma. R15.7 significantly reduced infarct size after adjusting for the effect of collateral flow (p = 0.0002, analysis of covariance). In a subgroup of dogs with collateral flow <30% of nonischemic flow, infarct size was reduced from 34.6 +/- 3.9% (mean +/- SE) of the region at risk in the control group to 19.5 +/- 3.3% in the antibody group (p = 0.008). Ejection fraction and regional chord shortening did not differ between the two groups at baseline or during occlusion, but after 48-h reperfusion, ejection fraction and inferior wall regional cord shortening (representing the infarct zone) were both higher in the R15.7 group than the control group (43.6 +/- 2.9% vs. 28.5 +/- 1.8%, p < 0.01; 2.55 +/- 0.29% vs. 1.06 +/- 0.18%, p < 0.05). CONCLUSIONS. A single injection of an anti-CD18 antibody given before reperfusion can limit myocardial infarct size by nearly 50% and preserve global and regional left ventricular function after 48 h of reperfusion.

This article has been cited by other articles:

				N. G. Frangogiannis Regulation of the Inflammatory Response in Cardiac Repair Circ. Res., January 6, 2012; 110(1): 159 - 173. [Abstract] [Full Text] [PDF]

				G. B. Segel, M. W. Halterman, and M. A. Lichtman The paradox of the neutrophil's role in tissue injury J. Leukoc. Biol., March 1, 2011; 89(3): 359 - 372. [Abstract] [Full Text] [PDF]

				A. Merched, K. Tollefson, and L. Chan {beta}2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice Cardiovasc Res, March 1, 2010; 85(4): 853 - 863. [Abstract] [Full Text] [PDF]

				J.-F. Legare, A. Oxner, O. Heimrath, T. Myers, and R. W. Currie Heat shock treatment results in increased recruitment of labeled PMN following myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3210 - H3215. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448. [Abstract] [Full Text] [PDF]

				M. Horiba, K. Kadomatsu, K. Yasui, J.-K. Lee, H. Takenaka, A. Sumida, K. Kamiya, S. Chen, S. Sakuma, T. Muramatsu, et al. Midkine Plays a Protective Role Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Apoptotic Reaction Circulation, October 17, 2006; 114(16): 1713 - 1720. [Abstract] [Full Text] [PDF]

				D. K. Glover, L. M. Riou, M. Ruiz, G. W. Sullivan, J. Linden, J. M. Rieger, T. L. Macdonald, D. D. Watson, and G. A. Beller Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1851 - H1858. [Abstract] [Full Text] [PDF]

				M. Madjid, I. Awan, J. T. Willerson, and S. W. Casscells Leukocyte count and coronary heart disease: Implications for risk assessment J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1945 - 1956. [Abstract] [Full Text] [PDF]

				D. P. Faxon, R. J. Gibbons, N. A. F. Chronos, P. A. Gurbel, F. Sheehan, and HALT-MI Investigators The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1199 - 1204. [Abstract] [Full Text] [PDF]

				J. A. Barrabes, D. Garcia-Dorado, M. Mirabet, R.-M. Lidon, B. Soriano, M. Ruiz-Meana, P. Pizcueta, J. Blanco, Y. Puigfel, and J. Soler-Soler Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs J. Am. Coll. Cardiol., January 2, 2002; 39(1): 157 - 165. [Abstract] [Full Text] [PDF]

				K. W. Baran, M. Nguyen, G. R. McKendall, C. T. Lambrew, G. Dykstra, S. T. Palmeri, R. J. Gibbons, S. Borzak, B. E. Sobel, S. G. Gourlay, et al. Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Circulation, December 4, 2001; 104(23): 2778 - 2783. [Abstract] [Full Text] [PDF]

				H. V. Barron, S. D. Harr, M. J. Radford, Y. Wang, and H. M. Krumholz The association between white blood cell count and acute myocardial infarction mortality in patients >=65 years of age: findings from the cooperative cardiovascular project J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1654 - 1661. [Abstract] [Full Text] [PDF]

				C. Duilio, G. Ambrosio, P. Kuppusamy, A. DiPaula, L. C. Becker, and J. L. Zweier Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2649 - H2657. [Abstract] [Full Text] [PDF]

				S. P. Jones, S. D. Trocha, M. B. Strange, D. N. Granger, C. G. Kevil, D. C. Bullard, and D. J. Lefer Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2196 - H2201. [Abstract] [Full Text] [PDF]

				J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen The role of neutrophils in myocardial ischemia-reperfusion injury Cardiovasc Res, September 1, 1999; 43(4): 860 - 878. [Abstract] [Full Text] [PDF]

				M. Arai, Y. Masui, P. Goldschmidt-Clermont, A. DiPaula, C. Siu, T. Kondo, and L. C. Becker P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusion J. Am. Coll. Cardiol., July 1, 1999; 34(1): 280 - 288. [Abstract] [Full Text] [PDF]

				A. J. Palazzo, S. P. Jones, W. G. Girod, D. C. Anderson, D. N. Granger, and D. J. Lefer Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2300 - H2307. [Abstract] [Full Text] [PDF]

				C. E. Rochitte, J. A. C. Lima, D. A. Bluemke, S. B. Reeder, E. R. McVeigh, T. Furuta, L. C. Becker, and J. A. Melin Magnitude and Time Course of Microvascular Obstruction and Tissue Injury After Acute Myocardial Infarction Circulation, September 8, 1998; 98(10): 1006 - 1014. [Abstract] [Full Text] [PDF]